Cited 0 times in 
Cited 0 times in 
Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial
https://orcid.org/0000-0003-0952-3679Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.